Internal Medicine, Banner University Medical Center, University of Arizona, Tucson, AZ, USA.
Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, NE, USA.
Surg Endosc. 2020 Aug;34(8):3352-3367. doi: 10.1007/s00464-019-07135-9. Epub 2019 Oct 3.
Gastric peroral endoscopic myotomy (G-POEM) is a novel minimally invasive technique in endosurgery. Data is limited as to its efficacy, safety, and predictive factors. We conducted this meta-analysis to evaluate the clinical outcomes of G-POEM and used the outcomes of surgical pyloroplasty as a comparator group in the treatment of refractory gastroparesis.
We searched multiple databases from inception through March 2019 to identify studies that reported on G-POEM and pyloroplasty in gastroparesis. Our primary outcome was to analyze and compare the pooled rates of clinical success, in terms of Gastroparesis Cardinal Symptom Index (GCSI) score and 4-h gastric emptying study (GES) results, with G-POEM and pyloroplasty.
Three hundred and thirty-two and 375 patients underwent G-POEM (11 studies) and surgical pyloroplasty (seven studies), respectively. The pooled rate of clinical success, based on the GCSI score, with G-POEM was 75.8% (95% CI 68.1-82.1, I = 50) and with surgical pyloroplasty was 77.3% (95% CI 66.4-85.4, I = 0), with no significance, p = 0.81. The pooled rate of clinical success, based on the 4-hour GES results, with G-POEM was 85.1% (95% CI 68.9-93.7, I = 74) and with surgical pyloroplasty was 84% (95% CI 64.4-93.8, I = 81), with no significance, p = 0.91. The overall adverse events were comparable. Based on meta-regression analysis, idiopathic gastroparesis, prior treatment with botulinum toxin and gastric stimulator seemed to predict clinical success with G-POEM.
G-POEM demonstrates clinical success in treating refractory gastroparesis. Idiopathic gastroparesis, prior treatment with botulinum injections and gastric stimulator appear to have positive predictive effects on the 4-h GES results after G-POEM. Outcomes seem comparable to surgical pyloroplasty.
胃经口内镜肌切开术(G-POEM)是内镜手术中的一种新型微创技术。关于其疗效、安全性和预测因素的数据有限。我们进行了这项荟萃分析,以评估 G-POEM 的临床结果,并将手术幽门成形术的结果作为比较组,用于治疗难治性胃轻瘫。
我们从开始到 2019 年 3 月通过多个数据库搜索了报告胃轻瘫中 G-POEM 和幽门成形术的研究。我们的主要结果是分析和比较 G-POEM 和手术幽门成形术的临床成功率,根据胃轻瘫 cardinal 症状指数(GCSI)评分和 4 小时胃排空研究(GES)结果。
分别有 332 例和 375 例患者接受了 G-POEM(11 项研究)和手术幽门成形术(7 项研究)。根据 GCSI 评分,G-POEM 的临床成功率为 75.8%(95%CI68.1-82.1,I=50),手术幽门成形术为 77.3%(95%CI66.4-85.4,I=0),无显著性差异,p=0.81。根据 4 小时 GES 结果,G-POEM 的临床成功率为 85.1%(95%CI68.9-93.7,I=74),手术幽门成形术为 84%(95%CI64.4-93.8,I=81),无显著性差异,p=0.91。总体不良事件相当。基于荟萃回归分析,特发性胃轻瘫、先前接受肉毒毒素和胃刺激治疗似乎预测 G-POEM 的临床成功。
G-POEM 治疗难治性胃轻瘫取得了临床成功。特发性胃轻瘫、先前接受肉毒杆菌注射和胃刺激治疗似乎对 G-POEM 后 4 小时 GES 结果有积极的预测作用。结果似乎与手术幽门成形术相当。